Chemistry
Machine Learning · Drug Discovery
Overview
A Turing test for pharmaceutical artificial intelligence adding medicinal chemists into discriminators in GANs.
Funding and backers
Total raised
$845k
1 round on record
Latest round
$845k
Venture round · Sep 2017 · 9 yr ago
The money's age
Long since its last round
109 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
2 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 11%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2017 | $845k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Chemistry Holdings, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Joshua HeldExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Inductive Bio builds machine learning models that predict the absorption, distribution, metabolism and toxicity properties of drug…
PostEra uses machine learning for medicinal chemistry, proposing synthesis routes and analogues for drug discovery programmes. Founded in…
deepmirror is an AI-native drug design platform built around curated, non-public experimental molecule property measurements such as…
Novogaia is an applied AI drug discovery company that builds machine learning systems to decode the chemistry of natural organisms…
Axon is an interactive AI platform that accelerates drug discovery by amplifying the utility of cheminformatics, physics-based simulation…
Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate…
Financials
Total raised
$845k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2017 | $845k | Details |
People
Joshua Held
Executive Officer, Director
Rob Dyrdek
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
How Claude is accelerating protein design and analytical chemistry
In this post, we share two results that show how Claude can help life scientists increase the pace of their research. In the first, we tested Claude's ability to design protein binders from scratch, a key step in creating protein-based drugs that has hist
Read more
Report
First human trials of designer protein therapies stun US neuroscientists
Chinese researchers are testing DREADDs, a gene therapy to turn down neuronal activity, in the clinic
Read more
Report
Editorial: Celebrating a chemical renaissance in space
Space is big again. Chemists should jump on the opportunity for exploratory research
Read more
Report
Chemists set electrons free and break a decades-old chemistry barrier
Chemists have developed a catalyst that breaks a long-standing rule governing which molecules receive electrons during chemical reactions. By releasing electrons directly into solution, the technique could unlock reactions-and potentially useful new molec
Read more
Report
Report
'Alien world chemistry' found in meteorite
Findings from a study on a meteorite that hit a New Jersey home in 2024 has come back saying it holds prebiotic molecules and other building blocks of life. NBC News' Gadi Schwartz talks to the lead author on the study Peter Jenniskens about their discove
Read more
Report
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Santa Monica
United States
HQ